Latest news
Urogen Pharma Q2 Earnings Call Highlights - TradingViewTradingView · Wed, 05 Aug 2026 20:04:05 GMTURGN: Q2 revenue soared on ZUSDURI growth, with robust pipeline and profitability outlook maintained - TradingViewTradingView · Wed, 05 Aug 2026 16:00:51 GMTUrogen Pharma Ltd reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 13:30:49 GMTURGN: Q2 2026 revenue jumped to $72.5M, net loss narrowed, and cash reserves remain strong - TradingViewTradingView · Wed, 05 Aug 2026 13:16:53 GMTURGN: ZUSDURI's rapid adoption fueled 73% revenue growth and a sharply reduced net loss in Q2 2026 - TradingViewTradingView · Wed, 05 Aug 2026 12:34:18 GMTUroGen Pharma Q2 revenue beats on strong ZUSDURI sales - TradingViewTradingView · Wed, 05 Aug 2026 12:11:39 GMTUroGen Reports $72.5M Q2 Revenue, $50.4M ZUSDURI Sales and $14.4M Net Loss - TradingViewTradingView · Wed, 05 Aug 2026 12:03:01 GMTURGN Q2'26 Earnings: EPS estimate is (0.27) USD - TradingViewTradingView · Tue, 04 Aug 2026 11:01:04 GMT